Intraoperative Methadone Use in Pediatric Burn Patients

Amanda Carlson1, David Pham2, Cayenne Price3

  • 1Legacy Emmanuel Medical Center, Legacy Medical Group Trauma and General Surgery, Portland, Oregon, USA.

Insights

Intraoperative methadone may reduce opioid use in pediatric burn patients. This study found decreased postoperative opioid consumption with methadone, with no observed adverse events, suggesting potential benefits for pediatric burn pain management.

Area of Science:

  • Pediatric Burn Care
  • Pain Management
  • Pharmacology

Background:

  • Pediatric burn injuries result in significant physical and mental health issues.
  • Opioids are standard for burn pain but raise concerns about dependence.
  • Methadone, an N-methyl-D-aspartate (NMDA) and mu-opioid receptor agonist, is effective in adults but less studied in children.

Purpose of the Study:

  • To compare postoperative opioid utilization in pediatric burn patients receiving intraoperative methadone versus those who did not.
  • To assess methadone-related complications in this pediatric population.

Main Methods:

  • Retrospective cohort study at a Level 1 Burn Center.
  • Comparison of opioid utilization (mg/kg morphine equivalents) within 36 hours postoperatively.
  • Chart review for methadone-related adverse events.

Main Results:

  • The methadone cohort showed decreased opioid utilization (0.54 mg/kg) compared to the control cohort (0.77 mg/kg).
  • No methadone-related adverse events were identified during chart review.
  • Statistical significance for reduced opioid use was not reached (P = .18).

Conclusions:

  • Methadone use appears beneficial in pediatric burn patients, potentially reducing overall opioid requirements.
  • Further prospective studies in larger pediatric populations are needed to confirm efficacy and safety.
  • Methadone may be a valuable adjunct in managing pediatric burn pain.

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
473
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
221
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
416